27th Apr 2007 10:42
Tepnel Life Sciences PLC27 April 2007 27 April 2007 Tepnel Life Sciences plc ('Tepnel' or the 'Company') Notice of AGM Manchester, UK. 27 April 2007, Tepnel Life Sciences plc (AIM: TED) is pleased toannounce that its AGM is to be held at 10:00am on the 3rd May 2007 at SeymourPierce Ltd, Bucklersbury House, 3 Queen Victoria St, London EC4N 8EL. - ends - For Further Information: Tepnel Life Sciences plc Ben Matzilevich, CEO Carol Smith Tel: + 44 (0)161 946 2200 Capital MS&L Mary Clark or Halina Kukula Tel: +44 (0) 20 7307 5330 Email: [email protected] Notes to Editors About Tepnel Life Sciences plc Tepnel Life Sciences (AIM:TED) is a UK-based international life sciencesproducts and services group with two divisions, Molecular Diagnostics andResearch Products & Services. The Company has laboratories, manufacturing andoperations in the USA, UK and France with 195 employees. TLS provides testkits, reagents and services to two highly synergistic markets, these beingMolecular Diagnostics and Biomedical Research. The company's strategy has beento identify high growth niche opportunities within these multi-billion poundmarkets. TLS focuses on these niche opportunities with internally developedproducts, patents, expertise and know-how as well as strategic acquisitions, todevelop a leadership position within these defined market segments. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TED.L